Type 1 diabetes affects more than 1 million north Americans. Transplantation of islets of Langerhans offers the promise of a cure by a simple injection into the liver. The recent report from Edmonton describing success in 15 consecutive patients has led to a multi-center trial to confirm reproducibility of these results and to worldwide interest in improving procedures. Effective quality assessment methods are needed to ensure safety and in vivo efficacy. Because insufficient viable islet volume or excessive damaged tissue may lead to failure, tools for reproducible quantitative evaluation of meaningful properties in islet preparations are prerequisites for consistent success of islet transplants, for improvements in islet isolation, and for the conduct of islet transplantation research. The development of such tools is needed because currently used methods are inadequate and not predictive of clinical outcome. This project is based on a central hypothesis: Accurate knowledge of islet quality prior to transplantation will be predictive of in vivo efficacy in the absence of immune rejection. Islet quality can be assessed quantitatively in both pure and impure preparations in terms of viable islet volume and the relative amounts of viable and dead tissue (fractional viability). Oxygen consumption rate (OCR) in conjunction with DNA measurements is the primary tool for assessing these properties. The objectives of this project are (1) to develop tools for reliable in vitro assessment of islet preparation quality prior to transplantation in terms of viable islet volume and fractional viability, (2) to systematically evaluate the predictive capability of these tools by following transplantation outcome in small animals; (3) to add these tools to existing methods to assess the quality of islet preparations for human transplantation, to generate a database of islet quality parameters, and to use it retrospectively to determine their usefulness in predicting in vivo efficacy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK063108-02
Application #
6802693
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Appel, Michael C
Project Start
2003-09-30
Project End
2006-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
2
Fiscal Year
2004
Total Cost
$172,714
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Johnson, Amy S; O'Sullivan, Esther; D'Aoust, Laura N et al. (2011) Quantitative assessment of islets of Langerhans encapsulated in alginate. Tissue Eng Part C Methods 17:435-49
Pisania, Anna; Weir, Gordon C; O'Neil, John J et al. (2010) Quantitative analysis of cell composition and purity of human pancreatic islet preparations. Lab Invest 90:1661-75
Papas, Klearchos K; Colton, Clark K; Qipo, Andi et al. (2010) Prediction of marginal mass required for successful islet transplantation. J Invest Surg 23:28-34
Pisania, Anna; Papas, Klearchos K; Powers, Daryl E et al. (2010) Enumeration of islets by nuclei counting and light microscopic analysis. Lab Invest 90:1676-86
Papas, Klearchos K; Suszynski, Thomas M; Colton, Clark K (2009) Islet assessment for transplantation. Curr Opin Organ Transplant 14:674-82
Papas, Klearchos K; Pisania, Anna; Wu, Haiyan et al. (2007) A stirred microchamber for oxygen consumption rate measurements with pancreatic islets. Biotechnol Bioeng 98:1071-82